Advantage-Alpha-Capital-Partners-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
146
Total Value
408256357
Accession Number
0001420506-25-001089
Form Type
13F-HR
Manager Name
Advantage-Alpha-Capital-Partners-Lp
Data Enrichment
100% identified
146 identified0 unidentified

Holdings

146 positions • $408.3M total value
Manager:
Search and click to pin securities to the top
Page 5 of 8
HELIOS TECHNOLOGIES, INC.
Shares:56.3K
Value:$1.8M
% of Portfolio:0.4% ($1.8M/$408.3M)
AZEK Co Inc.
Shares:36.3K
Value:$1.8M
% of Portfolio:0.4% ($1.8M/$408.3M)
DoubleVerify Holdings, Inc.
Shares:125.0K
Value:$1.7M
% of Portfolio:0.4% ($1.7M/$408.3M)
TREX CO INC
Shares:27.9K
Value:$1.6M
% of Portfolio:0.4% ($1.6M/$408.3M)
MASTEC INC
Shares:13.4K
Value:$1.6M
% of Portfolio:0.4% ($1.6M/$408.3M)
TrueBlue, Inc.
Shares:227.1K
Value:$1.2M
% of Portfolio:0.3% ($1.2M/$408.3M)
HALOZYME THERAPEUTICS, INC.
Shares:13.8K
Value:$882.5K
% of Portfolio:0.2% ($882.5K/$408.3M)
AUTONATION, INC.
Shares:5.1K
Value:$830.6K
% of Portfolio:0.2% ($830.6K/$408.3M)
TG THERAPEUTICS, INC.
Shares:20.6K
Value:$811.8K
% of Portfolio:0.2% ($811.8K/$408.3M)
PENSKE AUTOMOTIVE GROUP, INC.
Shares:5.4K
Value:$781.2K
% of Portfolio:0.2% ($781.2K/$408.3M)
VERACYTE, INC.
Shares:26.3K
Value:$779.3K
% of Portfolio:0.2% ($779.3K/$408.3M)
Core Scientific, Inc./tx
Shares:100.8K
Value:$730.1K
% of Portfolio:0.2% ($730.1K/$408.3M)
Alkermes plc.
Shares:21.4K
Value:$705.2K
% of Portfolio:0.2% ($705.2K/$408.3M)
ANI PHARMACEUTICALS INC
Shares:10.2K
Value:$682.8K
% of Portfolio:0.2% ($682.8K/$408.3M)
Krystal Biotech, Inc.
Shares:3.6K
Value:$643.5K
% of Portfolio:0.2% ($643.5K/$408.3M)
MIMEDX GROUP, INC.
Shares:81.6K
Value:$620.4K
% of Portfolio:0.2% ($620.4K/$408.3M)
COLLEGIUM PHARMACEUTICAL, INC
Shares:19.2K
Value:$572.0K
% of Portfolio:0.1% ($572.0K/$408.3M)
DYNAVAX TECHNOLOGIES CORP
Shares:38.4K
Value:$498.6K
% of Portfolio:0.1% ($498.6K/$408.3M)
CATALYST PHARMACEUTICALS, INC.
Shares:20.0K
Value:$485.9K
% of Portfolio:0.1% ($485.9K/$408.3M)
Protagonist Therapeutics, Inc
Shares:8.6K
Value:$417.5K
% of Portfolio:0.1% ($417.5K/$408.3M)